BXLT 22% - biotech spinoff, calculated risk
AAPL 18% - value in the company when bought and awaiting 2 year mark (Sept to sell for long term capital gains tax advantage)
GSK 16% - dividend with company value
MET 14% - dividend with company value
JCP 7% - risky, but could pay off
AAPL 18% - value in the company when bought and awaiting 2 year mark (Sept to sell for long term capital gains tax advantage)
GSK 16% - dividend with company value
MET 14% - dividend with company value
JCP 7% - risky, but could pay off
Last edited: